
"Sector" = median of Consumer Defensive across 72 companies
Altria Group, Inc. is a leading US-based tobacco company that primarily manufactures and sells cigarettes, smokeless tobacco products, and wine. Its flagship brand, Marlboro, is the largest-selling cigarette brand in the United States. The company also owns a significant stake in Anheuser-Busch InBev and has investments in cannabis through Cronos Group. Altria operates in a highly regulated industry and focuses on adult consumers aged 21 and over.
Altria generates revenue primarily from the sale of tobacco products through its subsidiaries. Its cigarette segment, led by Marlboro, accounts for the majority of revenue, with smokeless tobacco (Copenhagen, Skoal) and wine (Chateau Ste. Michelle) contributing smaller portions. The company has a strong distribution network and benefits from pricing power due to brand loyalty. Altria also earns income from its equity investment in AB InBev.
Altria operates in the consumer defensive sector within the tobacco industry, which is characterized by declining smoking rates but stable demand due to addiction and brand loyalty. The company is the largest cigarette maker in the US by market share, competing primarily with Reynolds American (British American Tobacco) and Imperial Brands. Its competitive advantages include strong brand equity, efficient supply chain, and high barriers to entry from regulation and excise taxes.
Altria's target audience is adult tobacco consumers aged 21 and over in the United States. The company markets its products through traditional retail channels, convenience stores, and direct marketing. While its geographic focus is almost entirely domestic, the US market remains highly profitable due to pricing power and a loyal customer base. Altria also explores reduced-risk products to address evolving consumer preferences.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Mar 25, 2026 | $1.06 | Apr 30, 2026 | Quarterly |
| Dec 26, 2025 | $1.06 | Jan 9, 2026 | Quarterly |
| Sep 15, 2025 | $1.06 | Oct 10, 2025 | Quarterly |
| Jun 16, 2025 | $1.02 | Jul 10, 2025 | Quarterly |
| Mar 25, 2025 | $1.02 | Apr 30, 2025 | Quarterly |
| Dec 26, 2024 | $1.02 | Jan 10, 2025 | Quarterly |
| Sep 16, 2024 | $1.02 | Oct 10, 2024 | Quarterly |
| Jun 14, 2024 | $0.98 | Jul 10, 2024 | Quarterly |
| Mar 22, 2024 | $0.98 | Apr 30, 2024 | Quarterly |
| Dec 20, 2023 | $0.98 | Jan 10, 2024 | Quarterly |
| Sep 14, 2023 | $0.98 | Oct 10, 2023 | Quarterly |
| Jun 14, 2023 | $0.94 | Jul 10, 2023 | Quarterly |
| Mar 23, 2023 | $0.94 | Apr 28, 2023 | Quarterly |
| Dec 21, 2022 | $0.94 | Jan 10, 2023 | Quarterly |
| Sep 14, 2022 | $0.94 | Oct 11, 2022 | Quarterly |
| Jun 14, 2022 | $0.90 | Jul 11, 2022 | Quarterly |
| Mar 24, 2022 | $0.90 | Apr 29, 2022 | Quarterly |
| Dec 22, 2021 | $0.90 | Jan 10, 2022 | Quarterly |
| Sep 14, 2021 | $0.90 | Oct 12, 2021 | Quarterly |
| Jun 14, 2021 | $0.86 | Jul 9, 2021 | Quarterly |
| Mar 24, 2021 | $0.86 | Apr 30, 2021 | Quarterly |
| Dec 24, 2020 | $0.86 | Jan 11, 2021 | Quarterly |
| Sep 14, 2020 | $0.86 | Oct 9, 2020 | Quarterly |
| Jun 12, 2020 | $0.84 | Jul 10, 2020 | Quarterly |
Wrqti brings Altria Group, Inc. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Consumer Defensive sector you can compare with Altria Group, Inc.:
Compare Altria Group, Inc. head-to-head with:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.